Prostate cancer (PCa) is second most common cause of cancer death among American men. Curently clinicians rely on needle biopsies for PCa grading, although biopsy Gleason scores often differ from those of pathological analyses. We demonstrated modified-DBSI captured and quantified heterogeneous diffusion fingerprints reflecting prostatic histopathology, capable of noninvasively grading PCa with high accuracy. The diagnostic power of modified-DBSI could prevent low-grade cancer patients from undergoing unnecessary and costly invasive procedures, offering patients more reliable assessments on cancer progression during active surveillance, and helping patients and clinicians to determine the most appropriate treatment options.
How to access this content:
For one year after publication, abstracts and videos are only open to registrants of this annual meeting. Registrants should use their existing login information. Non-registrant access can be purchased via the ISMRM E-Library.
After one year, current ISMRM & ISMRT members get free access to both the abstracts and videos. Non-members and non-registrants must purchase access via the ISMRM E-Library.
After two years, the meeting proceedings (abstracts) are opened to the public and require no login information. Videos remain behind password for access by members, registrants and E-Library customers.
Keywords